89bio
Developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases
123 employees · est. 2018 · San Francisco, United States
CORXEL Pharmaceuticals
Our mission is to develop innovative cardiometabolic therapies globally.
40 employees · est. 2019 · Shanghai, China
89bio is the older company (2018 vs 2019); 89bio is the larger of the two.
Side-by-Side Comparison
| Metric | 89bio | CORXEL Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2019 |
| Headquarters | ||
| Headquarters | San Francisco, United States | Shanghai, China |
| Employees | ||
| Employees | 123 larger | 40 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Series D |
| Total Funding | ||
| Total Funding | $773.20M | $162.00M |
| Funding Rounds | ||
| Funding Rounds | 7 | 2 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Clinical-stage, FGF21 Analog, NASH Treatment, SHTG Treatment, Liver Diseases, Cardio-metabolic Diseases, Innovative Therapies, Phase 2 Trial, Patient-centric, Ethical Standards, Scientific Advancement, San Francisco, Herzliya, Israel | Biopharmaceutical, Innovation, Therapeutics, Clinical Development, Ophthalmology, Cardiovascular, Global Partnerships, Patient-Centric, Unmet Medical Needs, China Healthcare, RTW Investments |
| Website | ||
| Website | 89bio.com | jixing.com |
About 89bio
89bio 89bio is a clinical-stage biopharmaceutical company with a focus on developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases. Their lead product candidate, BIO89-100, is an engineered glycoPEGylated analog of FGF21 designed for the treatment...
About CORXEL Pharmaceuticals
Jixing Pharmaceuticals, founded in 2019, is a biopharmaceutical company based in Shanghai, China. The company's slogan, "Our mission is to develop novel therapeutics, bridging the innovation gap for patients in China," reflects its dedication to bringing innovative science and medicines to underserv...
We will tell you when either one moves
BounceWatch watches 89bio and CORXEL Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at 89bio and CORXEL Pharmaceuticals — by email.
Frequently Asked Questions
Compare 89bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at 89bio on 9 Jun 2026, and CORXEL Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.